BEN vs CNTA · P/E 36, rev $8.77B vs $6.15B cap
Franklin Resources Inc (BEN) versus Centessa Pharmaceuticals PLC ADR (CNTA) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. CNTA currently screens at market cap $6.15B.
Not investment advice. Open the BEN and CNTA stock pages for the full models.
Not investment advice.